Evidence map›Paper›PMID 24799764›Full record

ArticleMediators of inflammation2014

MicroRNA profiling of activated and tolerogenic human dendritic cells.

Zuzana Stumpfova, Renata Hezova, Albano Carlo Meli, Ondrej Slaby, Jaroslav Michalek

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Pooled it
  2. MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis.International journal of nephrology and renovascular disease · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Zuzana StumpfovaDepartment of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Renata HezovaCEITEC, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic ; Masaryk Memorial Cancer Institute, Zlutý Kopec 7, 65653 Brno, Czech Republic.
Albano Carlo MeliDepartment of Biology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic ; INSERM U1046, University of Montpellier I and II, 371 avenue du Doyen G. Giraud, 34295 Montpellier, France.
Ondrej SlabyCEITEC, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic ; Masaryk Memorial Cancer Institute, Zlutý Kopec 7, 65653 Brno, Czech Republic.
Jaroslav MichalekDepartment of Pharmacology, Faculty of Medicine, Masaryk University, Kamenice 5, 62500 Brno, Czech Republic.
Masaryk University · CZMasaryk Memorial Cancer Institute · CZUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dendritic cells (DCs) belong to the immune system and are particularly studied for their potential to direct either an activated or tolerogenic immune response. The roles of microRNAs (miRNAs) in posttranscriptional gene expression regulation are being increasingly investigated. This study's aim is to evaluate the miRNAs' expression changes in prepared human immature (iDCs), activated (aDCs), and tolerogenic dendritic cells (tDCs). The dendritic cells were prepared using GM-CSF and IL-4 (iDC) and subsequently maturated by adding LPS and IFN-γ (aDC) or IL-10 and TGF-β (tDC). Surface markers, cytokine profiles, and miRNA profiles were evaluated in iDC, tDC, and aDC at 6 h and 24 h of maturation. We identified 4 miRNAs (miR-7, miR-9, miR-155 and miR-182), which were consistently overexpressed in aDC after 6 h and 24 h of maturation and 3 miRNAs (miR-17, miR-133b, and miR-203) and miR-23b cluster solely expressed in tDC. We found 5 miRNAs (miR-10a, miR-203, miR-210, miR-30a, and miR-449b) upregulated and 3 miRNAs downregulated (miR-134, miR-145, and miR-149) in both tDC and aDC. These results indicate that miRNAs are specifically modulated in human DC types. This work may contribute to identifying specific modulating miRNAs for aDC and tDC, which could in the future serve as therapeutic targets in the treatment of cancer and autoimmune diseases.

Indexed as

Cells, CulturedDendritic CellsFlow CytometryGranulocyte-Macrophage Colony-Stimulating FactorHumansInterleukin-10Interleukin-4LipopolysaccharidesMicroRNAsTransforming Growth Factor betaGranulocyte-Macrophage Colony-Stimulating FactorInterleukin-10Interleukin-4LipopolysaccharidesMicroRNAsMIRN10 microRNA, humanMIRN133 microRNA, humanMIRN17 microRNA, humanMIRN203 microRNA, humanMIRN210 microRNA, humanMIRN30b microRNA, humanMIRN449 microRNA, humanTransforming Growth Factor beta

Identifiers

PMID24799764
PMCPMC3995309
OpenAlexW2024713895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.